Abstract No. 261 Cost-effectiveness analysis of interventional liver-directed therapies for a single, small (< 3 cm) hepatocellular carcinoma in liver transplant candidates

Journal of Vascular and Interventional Radiology(2022)

Cited 0|Views3
No score
Abstract
In patients with a single hepatocellular carcinoma (HCC) ≤3 cm, locoregional therapy (LRT) is commonly performed while awaiting transplantation. The purpose is to assess the cost-effectiveness of the three main LRTs (transarterial chemoembolization (TACE), radioembolization (TARE), and percutaneous ablation) as bridging therapy.
More
Translated text
Key words
Treatment,Hepatocellular Carcinoma
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined